Alkermes plc (NASDAQ:ALKS) Spikes 40% After Positive Data From Depression Treatment Trial

in NASDAQ by

Alkermes Plc (NASDAQ:ALKS) is up more than 40 percent in Thursday’s after-hours session, after the company announced positive topline results from its late-stage clinical study of ALKS 5461 for the treatment of depression.

According to data out of FORWARD-5, the company’s third phase 3 efficacy study, ALKS 5461 considerably reduced the symptoms seen in patients with major depression disorder, compared to a placebo. Keep Reading

Twitter inc (NYSE:TWTR) : Slowing Revenue and User Growth Are Two Big Challenges Management Face

in NYSE by

Year over year, Twitter’s registered user count grew only roughly 3% in Q2. The first quarter of last year saw a 3% growth in itself and the same quarter last year saw a 15% growth. Compare that to Facebook’s 15% annual growth and the hesitation among business owners to invest in Twitter’s promoted tweet advertising can partially be attributed to that lack of active user growth. Repeat business is difficult to retain if the advertising base remains very similar or changes only marginally over the period of an entire year. Keep Reading

Newmont Mining Corp (NYSE:NEM) : Current drop creates opportunities for investors positioning for rally

in NYSE by

Newmont Mining Corp is a global mining company mainly involved in the mining of gold and copper. It operates in U.S., Australia, Peru, Indonesia, Ghana, Canada, New Zealand and Mexico. The company has gold reserves of approximately 73.7 million ounces and its aggregate land areas cover approximately 20,000 square miles (over 52,000 square kilometers). Keep Reading

GW Pharmaceuticals (NASDAQ:GWPH) is continuing to see bullish factors for its business prospects

in NASDAQ by

 Phase 3 FDA approval and commercial sales for “Epidiolex” drug in the treatment of childhood epilepsies are now close, though not of course guaranteed.

New legal changes in the U.K. on medical marijuana open up substantial opportunities for the sector. Within the sector as a whole GW Pharma has become increasingly the only serious Keep Reading

Microsoft reports rising revenues , stock posted a new all time high

in NASDAQ by

Microsoft Corp (MSFT) reported adjusted revenue and profit above estimates on Thursday, driven by growing demand for its cloud products and services.

Microsoft’s shares were up 5.2 percent at $60.21 in extended trading.

Revenue from the company’s increasingly important “Intelligent Cloud” business, which includes the Azure cloud platform and server software, rose 8.3 percent to $6.38 billion. Keep Reading

Facebook inc (NASDAQ:FB) has added a new food-delivery option to its social networking website

in NASDAQ by

According to the company’s blog post:

You can now order food from restaurants directly from their Facebook Pages. Simply click “Start Order” on any restaurant’s Facebook Page that uses or Slice.

The company began rolling out this new feature yesterday, which most U.S. users can now begin using within its mobile app. Keep Reading

Wednesday Pre Market Losers



  • Sangamo Biosciences, Inc. SGMO shares fell 23 percent to $3.00 in the pre-market trading session after gaining 1.30 percent on Tuesday.
  • Imperva Inc IMPV shares fell 16.8 percent to $38.80 in pre-market trading following reports circulating that the sale talks have stalled due to issues regarding price.
  • Cree, Inc. CREE shares fell 9.9 percent to $22.70 in pre-market trading after the company issued a weak earnings forecast for the fiscal second quarter.
  • Comstock Resources Inc CRK shares fell 9.2 percent to $7.88 in pre-market trading after rising 5.08 percent on Tuesday.
  • Acadia Healthcare Company Inc ACHC shares fell 7.1 percent to $42.00 in pre-market trading after the company reported the signing of definitive deal for sale of UK facilities in fulfillment of previously announced undertakings to the CMA. The company issued a weak forecast for the third quarter.
  • Puma Biotechnology Inc PBYI fell 5 percent to $50.00 in pre-market trading after the company announced a $150 million offering of common stock.
  • Intel Corporation INTC shares fell 4.4 percent to $36.08 in pre-market trading. Intel reported better-than-expected earnings for its third quarter, but issued a weak revenue forecast for the current quarter.
  • Nektar Therapeutics NKTR fell 4.1 percent to $13.51 in pre-market trading after dropping 10.15 percent on Tuesday.
  • Ascendis Pharma A/S ASND shares fell 3.9 percent to $19.30 in pre-market trading. Ascendis Pharma priced its 6.3 million share offering at $19 per ADS.

Wednesday Pre Market Gainers



  • Cerulean Pharma Inc CERU rose 110 percent to $1.450 in the pre-market trading session following announcement of a collaboration with Novartis.
  • Banc of California Inc BANC rose 15.4 percent to $12.99 in pre-market trading as the company reported better-than-expected earnings for its latest quarter.
  • Omeros Corporation OMER rose 10 percent to $8.25 in the pre-market trading after announcing positive data from a Phase 2 clinical trial evaluating PPAR-gamma agonist in cocaine abuse.
  • GNC Holdings Inc GNC rose 7 percent to $20.75 in pre-market trading after the Wall Street Journal reported that the company has met with “Chinese buyers in recent weeks to gauge interest in a potential buyout.”
  • Amarin Corporation plc (ADR) AMRN rose 5.3 percent to $3.16 in pre-market trading. Citigroup initiated coverage on Amarin with a Buy rating and a $5.00 price target.
  • Seagate Technology PLC STX shares rose 3.8 percent to $36.68 in pre-market trading after reporting better-than-expected quarterly earnings.
  • Yahoo! Inc. YHOO shares rose 1 percent to $42.10 in pre-market trading as the company reported upbeat earnings for the third quarter on Tuesday.


(OTC:NTDOY) DFC Intelligence Forecasts Game Software to Reach $98 Billion by 2020


Video Game Industry analyst firm DFC Intelligence has issued its latest forecast for the global video game market indicating that growth in the game industry is being driven by digital sales of games and high-end hardware. In 2016 overall game software sales are expected to be up 8% to $79 billion. This is despite a slowdown in sales of packaged game software. By 2020, global video game software sales is expected to reach $98 billion with a CAGR of over 5%. Keep Reading

1 2 3 8
Go to Top